Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells

This publication has 14 references indexed in Scilit:

• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• P-glycoprotein possesses A 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site
  Biochemical and Biophysical Research Communications, 1992
• Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Photoaffinity substrates for P-glycoprotein
  Biochemical Pharmacology, 1992
• Functional Architecture of the Nicotinic Acetylcholine Receptor: From Electric Organ to Brain
  Annual Review of Pharmacology and Toxicology, 1991
• B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance
  International Journal of Cancer, 1991
• THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
  Annual Review of Biochemistry, 1989
• (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of α1-adrenoceptors
  European Journal of Pharmacology: Molecular Pharmacology, 1989
• Structure and Function of Voltage-Sensitive Ion Channels
  Science, 1988
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973